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The most common form of implant infection is a staph infection.

Based on the results from the literature review of research it seems as
though there is a potential of having a thin layer of antimicrobial
agents around a breast implant. And that this layer of antimicrobial
agents can be effective in combating staph infections. However,
further research is still needed in discovering the amount of antibiotics
best suited to surround the implant without harming the patient yet still
be effective in combating staph infections in its early stages. In
addition, further research needs to be completed where human subjects
are involved. Also, further research needs to be completed in
addressing possible complications if this were to ever be marketed into
the medical field. Lastly, future implications that can be used from
this research is to compare it with other implants to see if it too is
possible to create an implant with an antimicrobial layer to combat
common infections present in those implants.

Staph infections are caused by the bacteria staphylococcus, which is a
biofilm that grows on top of one another while encasing the implant.
Most of the time a staph infection tends to infect breasts implants. This
is the most common implant that staphylococcus tends to grow on
because of the general layout of the surgical procedure for breast
augmentation.
As of now treatment options to treat this are oral, intravenous
antibiotics, or surgery. Even though these methods have a low
mortality rate, the efficiency of these methods are low and are costly.
Therefore, there needs to be a more affordable and efficient way to
treat staph infections. One way is to have a thin layer of antibiotics
around the implant before it is surgically placed in a patient.
Presently, there are multiple ways to treat staph infections around a
breast implant. However, these options have a low success rate and
target the infection after it has developed. Therefore, there needs to be
an option to treat staph infections before they occur. That is why a
layer of antimicrobial agents is needed to surround the breast implant
because this will reduce the presence of staph infections, and the use
for inefficient treatment.

Figure 2: Results of various antimicrobial agents used to combat staph infections
around breast implants.
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Figure 4: Removal of mini-breast implants with a coat of Vancomycin from rats.
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Figure1: types of breast implants currently on the market.
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Methods and Materials:
In order to create a proper review of research, multiple perspectives
were used. This created a well balanced paper to fully address the pros
and cons to this question. The first perspective is to draw in sources
that complete studies that use antimicrobial agents to treat staph
infections around the breast implant. The second perspective is using
other agents to surround the implant to prevent staph infections
besides antimicrobial infections. The third and final perspective is to
obtain articles that make the claim that pre-operative methods can be
put in place or improving pre-operative methods can result in staph
infection decrease. Therefore there is no need for a layer of
antimicrobial agents to be placed around the implant.
All these perspectives provided data that allowed for a level of
comparison to see which method to reduce staph infections is most
affective.

Figure 3: Results from having layer of Vancomycin surround breast implants to
combat staph infections.
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